Negative regulation of skeletal muscle cell proliferation

pathway activity — cross-omics
GO:0014859Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of skeletal muscle cell proliferation pathway is significantly associated with the protein abundance of multiple proteins, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are ANXA2_T19, MET, and SFN, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of skeletal muscle cell proliferation activity versus ANXA2_T19 in BRCA (Pearson r = -0.07).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCAANXA2_T19 →+0.467+0.063.001<.00137
OVMET →+0.647+0.073.001<.00136
BRCASFN →+0.633+0.054<.001<.00136
BRCAC1orf116 →+0.774+0.053<.001.00136
HNSCLAMC2 →+0.742+0.098.001.00336
PDACPPL →+0.434+0.078<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0014859 vs ANXA2_T19 — BRCA

Per-sample scatter of Negative regulation of skeletal muscle cell proliferation activity vs ANXA2_T19 in BRCA.

Explore this scatter interactively →

Exploration